PRISM-GENOMICS-Smoking Cessation for Patients With Coronary Artery Disease Undergoing Cardiac Catheterization or Having a Heart Attack at Barnes Hospital in St. Louis Mo
Angina and Genotype-Guided Smoking Cessation In PRISM-GENOMICS
Sponsor: Washington University School of Medicine
A NA clinical study on Coronary Artery Disease and Smoking Cessation, this trial is ongoing. The trial is conducted by Washington University School of Medicine and has accumulated 10 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Aug 2025 — Sep 2025 [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Dec 2021 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2019 — Sep 2020 [monthly]
Recruiting NA
-
Jun 2018 — Jul 2019 [monthly]
Recruiting NA
-
Jan 2018 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .